Publications by authors named "E Makonnen"

Article Synopsis
  • Ethiopia is working towards eliminating mother-to-child transmission (MTCT) of HIV by 2030, with a focus on optimizing Dolutegravir-based antiretroviral treatment (ART) since 2020.
  • A study analyzed HIV-exposed infants enrolled in Prevention of Mother-to-Child Transmission (PMTCT) care from 2017 to 2022, indicating low rates of HIV positivity at various intervals: 1.2% at 6-8 weeks, 0.50% during breastfeeding, and 1.8% by the end of care.
  • Results suggested a decreasing trend in transmission rates after the introduction of the DTG-based regimen; however, statistical significance was not achieved, and
View Article and Find Full Text PDF

Background: A dolutegravir (DTG)-based antiretroviral regimen has been rolled out for pregnant women in low- and middle-income countries since 2020. However, available safety data are limited to a few clinical trials and observational studies. Hence, we present real-world pregnancy and birth outcome safety data from a large sample multicenter cohort study in Ethiopia.

View Article and Find Full Text PDF

Continuous professional development among stakeholders involved in drug safety monitoring and surveillance is imperative in strengthening pharmacovigilance (PV) systems. The "Pharmacovigilance infrastructure and post-marketing surveillance system capacity building for regional medicine regulatory harmonization in East Africa" (PROFORMA) project aims to enhance the national PV infrastructure, post-marketing surveillance systems and clinical trial regulatory capabilities in Ethiopia, Tanzania, Kenya and Rwanda. To achieve this, training, including short-term training (STT) activities, at various levels is required.

View Article and Find Full Text PDF

Metabolism of praziquantel (PZQ), a racemic mixture and the only drug approved to treat S. mansoni infection, is mediated by genetically polymorphic enzymes. Periodic school-based mass drug administration (MDA) with PZQ is the core intervention to control schistosomiasis.

View Article and Find Full Text PDF

Background: Diabetes mellitus (DM) increases cardiovascular disease (CVD) incidence and mortality. While guidelines endorse statin use in type 2 DM (T2DM) to mitigate cardiovascular risks and mortality, challenges like statin initiation and prompt treatment adjustments affect patient outcomes. This study aimed to assess the appropriateness of indications for and dose intensification of statin therapy among T2DM patients at Tikur Anbessa Specialized Hospital (TASH).

View Article and Find Full Text PDF